Oral ivermectin for a scabies outbreak in a long‐term care facility: potential value in preventing COVID‐19 and associated mortality

A gene for an autosomal dominant scleroatrophic syndrome predisposing to skin cancer (Huriez syndrome) maps to chromosome 4q23.

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 184; no. 6; pp. 1207 - 1209
Main Authors Bernigaud, C., Guillemot, D., Ahmed‐Belkacem, A., Grimaldi‐Bensouda, L., Lespine, A., Berry, F., Softic, L., Chenost, C., Do‐Pham, G., Giraudeau, B., Fourati, S., Chosidow, O.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.06.2021
Wiley
John Wiley and Sons Inc
Subjects
Administration, Oral
Antiparasitic Agents
Correspondence
COVID-19
Disease Outbreaks
Humans
Ivermectin
Life Sciences
Long-Term Care
Research Letter
SARS-CoV-2
Scabies
Online AccessGet full text
ISSN0007-0963
1365-2133
1365-2133
DOI10.1111/bjd.19821

Cover

More Information
Summary:A gene for an autosomal dominant scleroatrophic syndrome predisposing to skin cancer (Huriez syndrome) maps to chromosome 4q23.
Bibliography:Funding sources: The double‐blind randomized controlled trial GALECRUSTED (NCT02841215) is funded by the French Ministry of Health (Programme Hospitalier de Recherche Clinique, 2014 AOM14612) and supported by a grant from the French Society of Dermatology (March 2019).
D.G. and A.A‐B. contributed equally. L.G‐B. and A.L. contributed equally. B.G. and S.F. contributed equally.
Conflicts of interest: C.B. and O.C. act as unpaid scientific advisors for Medicines Development for Global Health. O.C. is the principal investigator of the RCT ‘Dose‐finding Study of Moxidectin for Treatment of Scabies’ (NCT03905265). G.D‐P. is the principal investigator, B.G. is the main statistician and O.C. is the scientific head of the RCT ‘Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies ‘GALECRUSTED’ (NCT02841215).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Correspondence-1
PMCID: PMC8013623
ISSN:0007-0963
1365-2133
1365-2133
DOI:10.1111/bjd.19821